Literature DB >> 16384560

Low-density lipoprotein oxidized to various degrees activates ERK1/2 through Lox-1.

Hiroyuki Tanigawa1, Shin-Ichiro Miura, Bo Zhang, Yoshinari Uehara, Yoshino Matsuo, Masahiro Fujino, Tatsuya Sawamura, Keijiro Saku.   

Abstract

Although the standard procedure for preparing extensively oxidized low-density lipoprotein (Ox-LDL) is to incubate it with 10muM CuSO(4) at 37 degrees C for 24h, it is not well known how important the degree of oxidation of LDL is for inducing cell signaling. Since Lox-1 (an Ox-LDL receptor) contributes to cell proliferation through extracellular-signal-regulated kinase (ERK)1/2 activation and subsequently induces plaque growth, we analyzed ERK activity using LDL with various degrees of oxidation, from minimally Ox-LDL, which is mainly in human plasma, to extensively Ox-LDL using capillary electrophoresis (cITP). The cITP was a suitable tool for evaluating the degree of oxidation of LDL for analyzing the optimal conditions for the oxidation of LDL by CuSO(4) to obtain LDL that was oxidized to a degree comparable to that in human plasma. In addition, both minimally and extensively Ox-LDL induced similar levels of ERK1/2 activation through Lox-1 in human coronary artery smooth muscle cells. These results indicate that both minimally and extensively Ox-LDL may be important for the progression of plaque growth through Lox-1. Since most previous reports have provided data only using extensively Ox-LDL, a re-evaluation is needed to analyze several signals that use LDL which has been oxidized to various degrees.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16384560     DOI: 10.1016/j.atherosclerosis.2005.10.046

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

1.  Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins.

Authors:  Ruomei Li; Ana Oteiza; Karen Kristine Sørensen; Peter McCourt; Randi Olsen; Bård Smedsrød; Dmitri Svistounov
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-28       Impact factor: 4.052

2.  Oxidized LDL induces FAK-dependent RSK signaling to drive NF-κB activation and VCAM-1 expression.

Authors:  Arif Yurdagul; Florian J Sulzmaier; Xiao L Chen; Christopher B Pattillo; David D Schlaepfer; A Wayne Orr
Journal:  J Cell Sci       Date:  2016-02-18       Impact factor: 5.285

3.  Serum sLOX-1 Levels Are Correlated with the Presence and Severity of Obstructive Sleep Apnea.

Authors:  Chun-Yan Xu; Da-Ju Li; Chun-Ling Wu; Han-Jian Lou; Hong-Wei Jiang; Guo-Qiang Ding
Journal:  Genet Test Mol Biomarkers       Date:  2015-03-31

4.  Combined effects of niacin and chromium treatment on vascular endothelial dysfunction in hyperlipidemic rats.

Authors:  N Niu; Y H Yu; Y Wang; L J Wang; Q Li; L M Guo
Journal:  Mol Biol Rep       Date:  2008-07-12       Impact factor: 2.316

5.  Effects of dietary cold-pressed turnip rapeseed oil and butter on serum lipids, oxidized LDL and arterial elasticity in men with metabolic syndrome.

Authors:  Ari Palomäki; Hanna Pohjantähti-Maaroos; Marja Wallenius; Päivi Kankkunen; Heikki Aro; Sari Husgafvel; Juha-Matti Pihlava; Kalevi Oksanen
Journal:  Lipids Health Dis       Date:  2010-12-01       Impact factor: 3.876

6.  Human serum amyloid A3 (SAA3) protein, expressed as a fusion protein with SAA2, binds the oxidized low density lipoprotein receptor.

Authors:  Takeshi Tomita; Katsuaki Ieguchi; Tatsuya Sawamura; Yoshiro Maru
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

7.  LOX-1 plays an important role in ischemia-induced angiogenesis of limbs.

Authors:  Takeru Shiraki; Takuma Aoyama; Chiharu Yokoyama; Yuka Hayakawa; Toshiki Tanaka; Kazuhiko Nishigaki; Tatsuya Sawamura; Shinya Minatoguchi
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

Review 8.  Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1.

Authors:  Torben Mentrup; Florencia Cabrera-Cabrera; Bernd Schröder
Journal:  Front Cardiovasc Med       Date:  2021-01-20

9.  Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity.

Authors:  Silvia Biocca; Mattia Falconi; Ilaria Filesi; Francesco Baldini; Lucia Vecchione; Ruggiero Mango; Francesco Romeo; Giorgio Federici; Alessandro Desideri; Giuseppe Novelli
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.